What is Wall Street's Target Price for Adagio Therapeutics Inc (ADGI) Stock Monday?

Monday, August 22, 2022 12:51 PM | InvestorsObserver Analysts

Mentioned in this article

What is Wall Street's Target Price for Adagio Therapeutics Inc (ADGI) Stock Monday?

Analysts who follow Adagio Therapeutics Inc (ADGI) on average expect it to decline -8.74% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns ADGI an Analyst Ranking of 3, which means it ranks higher than 3 of stocks, based on data compiled by InvestorsObserver.

Wall Street analysts are rating ADGI a Hold today. Find out what this means to you and get the rest of the rankings on ADGI!

See Full ADGI Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Adagio Therapeutics Inc Stock Today?

Adagio Therapeutics Inc (ADGI) stock is trading at $4.20 as of 12:50 PM on Monday, Aug 22, of $0.00, or 0% from the previous closing price of $4.20. Volume today is elevated. So far 984,030 shares have traded compared to average volume of 599,997 shares. The stock has traded between $4.09 and $4.90 so far today. Click Here to get the full Stock Report for Adagio Therapeutics Inc stock.